Calculate the CIWA-Ar score (Clinical Institute Withdrawal Assessment for Alcohol) to assess alcohol-withdrawal severity and place the result in pathway context.
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) Calculator is the standard structured tool for assessing alcohol withdrawal severity. Used in emergency departments, detox units, and inpatient wards, the CIWA-Ar provides a 10-item scoring system that rates symptoms from nausea and tremor to hallucinations and disorientation, yielding a composite score from 0 to 67.
Alcohol withdrawal is a potentially life-threatening condition that occurs when a person with alcohol dependence suddenly reduces or stops drinking. Symptoms range from mild anxiety and tremors (6–12 hours after last drink) to seizures (12–48 hours) and delirium tremens (48–96 hours), which carries a 1–5% mortality rate without treatment. The CIWA-Ar helps quantify withdrawal burden and summarize where the patient sits on the severity spectrum.
This calculator scores each of the 10 CIWA-Ar domains and provides the total score with severity classification, pathway context, and visual breakdowns of each component. Symptom-triggered pathways guided by CIWA-Ar scores have been shown to reduce total benzodiazepine use and shorten treatment duration compared with fixed-dose approaches.
Alcohol withdrawal can escalate rapidly from mild symptoms to life-threatening seizures and delirium tremens. The CIWA-Ar gives clinicians a standardized way to summarize withdrawal severity and compare that score with the withdrawal pathway being used locally.
CIWA-Ar Total = Nausea (0–7) + Tremor (0–7) + Sweats (0–7) + Anxiety (0–7) + Agitation (0–7) + Tactile (0–7) + Auditory (0–7) + Visual (0–7) + Headache (0–7) + Orientation (0–4) Maximum Score: 67 Severity: • ≤ 8: Mild withdrawal • 9–15: Moderate withdrawal • 16–20: Severe withdrawal • > 20: Very severe (high risk of delirium tremens)
Result: CIWA-Ar Score: 20 — Severe Withdrawal
The total is 4+3+3+4+2+1+1+0+2+0 = 20. A score of 16–20 indicates severe withdrawal. At this level, the patient is at elevated risk for progression to seizures or delirium tremens, and clinicians usually compare the score with the formal withdrawal pathway being used.
Chronic alcohol use enhances GABA inhibition and suppresses NMDA excitatory signaling. When alcohol is withdrawn, the brain enters a hyperexcitable state with excessive glutamate activity and reduced GABAergic tone. This causes the spectrum of withdrawal symptoms: tremor, anxiety, autonomic instability, seizures, and potentially delirium tremens.
Many hospitals use CIWA-Ar every 1-2 hours during active withdrawal, then reduce reassessment frequency once the bedside picture stabilizes. The score is most useful when viewed alongside vital signs, prior withdrawal history, comorbid illness, and the pathway the treating team is using. It should be treated as a structured severity measure, not as a stand-alone medication engine.
Factors that increase risk of severe withdrawal and delirium tremens include history of previous DT or withdrawal seizures, heavy prolonged use, concurrent medical illness, advanced age, abnormal liver function, and a high CIWA-Ar score on initial assessment. These features often push clinicians toward more cautious monitoring and escalation decisions regardless of the single numeric score.
Last updated:
This worksheet adds the ten CIWA-Ar item scores into the standard 0-67 total and maps that total to the usual mild, moderate, severe, and very severe withdrawal bands. It keeps the item-level pattern visible so tremor, autonomic symptoms, perceptual disturbances, and disorientation can be reviewed together.
The score is a structured severity measure, not a stand-alone medication order set. CIWA-Ar works best when it is interpreted alongside vital signs, prior withdrawal history, seizure or delirium-tremens risk, concurrent illness, and the local withdrawal pathway.
The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is a validated 10-item clinical tool that quantifies the severity of alcohol withdrawal on a scale of 0–67. It was developed by Sullivan et al. in 1989 and is the most widely used assessment for managing alcohol withdrawal in clinical settings.
Hospitals commonly use CIWA-Ar at intake for patients at risk of alcohol withdrawal and then repeat it during active withdrawal. The exact timing varies by local pathway, staffing model, and severity of symptoms. It should not be used in patients who are actively intoxicated.
Many symptom-triggered pathways become more active once the CIWA-Ar score reaches the moderate range, often around 8-10 or higher. The exact medication threshold, drug choice, and reassessment interval vary by institution and patient-specific factors.
Delirium tremens (DT) is the most severe form of alcohol withdrawal, occurring in 3–5% of withdrawal cases, usually 48–96 hours after the last drink. Symptoms include severe agitation, confusion, hallucinations, fever, tachycardia, and seizures. Untreated DT has a mortality rate of up to 37%, reduced to 1–5% with appropriate treatment.
No. CIWA-Ar is validated specifically for alcohol withdrawal. For benzodiazepine withdrawal, the CIWA-B (Clinical Institute Withdrawal Assessment for Benzodiazepines) or the BWS (Benzodiazepine Withdrawal Symptom Questionnaire) should be used instead.
Symptom-triggered therapy gives medication only when CIWA-Ar scores exceed a pathway threshold. Fixed-dose therapy gives scheduled doses regardless of symptoms. Studies generally show symptom-triggered approaches use less medication and shorten treatment duration in appropriately monitored settings.